Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Langer

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancerGlen J Weiss, Corey Langer, Rafael Rosell, et al.
Oncotarget|September 23, 2016
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imagingXiao Chen, Yizeng Yang, Ian Berger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2009
Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trialsRogerio Lilenbaum, Victoria M Villaflor, Corey Langer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
HER2 expression in salivary gland carcinomas: dependence on histological subtypeBonnie Glisson, A Dimitrios Colevas, Robert Haddad, et al.
Cancer Causes & Control : CCC|January 21, 2010
A bupropion smoking cessation clinical trial for cancer patientsRobert A Schnoll, Elisa Martinez, Kristina L Tatum, et al.
Psycho-Oncology|May 25, 2016
The use of varenicline to treat nicotine dependence among patients with cancerSarah Price, Brian Hitsman, Anna Veluz-Wilkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancerNasser Hanna, Paul A Bunn, Corey Langer, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapyCharu Aggarwal, Xingmei Wang, Anjana Ranganathan, et al.
Practical Radiation Oncology|March 6, 2015
Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guidelineGeorge Rodrigues, Gregory M M Videtic, Ranjan Sur, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 24, 2003
Longitudinal predictors of continued tobacco use among patients diagnosed with cancerRobert A Schnoll, Calvin James, Michael Malstrom, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancerGlen J Weiss, Corey Langer, Rafael Rosell, et al.
Oncotarget|September 23, 2016
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imagingXiao Chen, Yizeng Yang, Ian Berger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2009
Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trialsRogerio Lilenbaum, Victoria M Villaflor, Corey Langer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
HER2 expression in salivary gland carcinomas: dependence on histological subtypeBonnie Glisson, A Dimitrios Colevas, Robert Haddad, et al.
Cancer Causes & Control : CCC|January 21, 2010
A bupropion smoking cessation clinical trial for cancer patientsRobert A Schnoll, Elisa Martinez, Kristina L Tatum, et al.
Psycho-Oncology|May 25, 2016
The use of varenicline to treat nicotine dependence among patients with cancerSarah Price, Brian Hitsman, Anna Veluz-Wilkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancerNasser Hanna, Paul A Bunn, Corey Langer, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapyCharu Aggarwal, Xingmei Wang, Anjana Ranganathan, et al.
Practical Radiation Oncology|March 6, 2015
Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guidelineGeorge Rodrigues, Gregory M M Videtic, Ranjan Sur, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 24, 2003
Longitudinal predictors of continued tobacco use among patients diagnosed with cancerRobert A Schnoll, Calvin James, Michael Malstrom, et al.
Pageof 11